by Discovery | Jul 27, 2022 | Events
After 22 years at Virginia Tech, executive committee chair Paul Carlier is joining the University of Illinois Chicago’s collaborative drug discovery center as their new director. He will also serve a joint appointment in the Departments of Pharmaceutical...
by Discovery | Mar 9, 2022 | Uncategorized
Elizabeth R. Sharlow, Professor of Research, Pharmacology in University of Virginia’s School of Medicine discusses UVA’s Fiske Drug Discovery Laboratory where impactful pharmacological research occurs every day. UVA graduate and undergraduate students are...
by Discovery | Feb 18, 2022 | Featured Collaboration
Charlottesville, Virginia – February 2022 KeViRx, Inc. (“KeViRx”) has been selected to join Blue Knight, a joint initiative between Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority (BARDA), a component of...
by Discovery | Jan 6, 2022 | Grants
Umesh Desai, VaDDC executive committee member and chair of Virginia Commonwealth University’s medicinal chemistry department, has just received an R61/33 grant to develop allosteric inhibitors of coagulation factor XIa. The grant, titled “Lead...
by Discovery | Oct 1, 2021 | Uncategorized
KeViRx is an early stage drug discovery company spun out of the UVA Department of Pharmacology by Elizabeth Sharlow and John Lazo and is located in Charlottesville. KeViRx was just awarded its second National Institutes of Health R43 Phase 1 Small Business Innovation...
